Transjugular intrahepatic portosystemic shunt treatment of variceal bleeding in an unselected patient population

References

• de Franchis R. Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: stratifying risk and individualizing care for portal hypertension. J Hepatol. 2015;63:743–752.
   PubMed Web of Science ®Google Scholar
• Zheng M, Chen Y, Bai J, et al. Transjugular intrahepatic portosystemic shunt versus endoscopic therapy in the secondary prophylaxis of variceal rebleeding in cirrhotic patients: meta-analysis update. J Clin Gastroenterol. 2008;42:507–516.
   PubMed Web of Science ®Google Scholar
• Sauerbruch T, Mengel M, Dollinger M, et al. Prevention of rebleeding from esophageal varices in patients with cirrhosis receiving small-diameter stents versus hemodynamically controlled medical therapy. Gastroenterology. 2015;149:660–668.
   PubMed Web of Science ®Google Scholar
• Bilbao JI, Quiroga J, Herrero JI, et al. Transjugular intrahepatic portosystemic shunt (TIPS): current status and future possibilities. Cardiovasc Intervent Radiol. 2002;25:251–269.
   PubMed Web of Science ®Google Scholar
• Bissonnette J, Garcia-Pagán JC, Albillos A, et al. Role of the transjugular intrahepatic portosystemic shunt in the management of severe complications of portal hypertension in idiopathic noncirrhotic portal hypertension. Hepatology. 2016;64:224–231.
   PubMed Web of Science ®Google Scholar
• Pugh RN, Murray-Lyon IM, Dawson JL, et al. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973;60:646–649.
   PubMed Web of Science ®Google Scholar
• Ferral H, Gamboa P, Postoak DW, et al. Survival after elective transjugular intrahepatic portosystemic shunt creation: prediction with model for end-stage liver disease score. Radiology. 2004;231:231–236.
   PubMed Web of Science ®Google Scholar
• Vilstrup H, Amodio P, Bajaj J, et al. Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver. Hepatology. 2014;60:715–735.
   PubMed Web of Science ®Google Scholar
• Rossle M, Haag K, Ochs A, et al. The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding. N Engl J Med. 1994;330:165–171.
   PubMed Web of Science ®Google Scholar
• Rosenqvist K, Eriksson L-G, Rorsman F, et al. Endovascular treatment of acute and chronic portal vein thrombosis in patients with cirrhotic and non-cirrhotic liver. Acta Radiol. 2016;57:572–579.
   PubMed Web of Science ®Google Scholar
• Holster IL, Tjwa ETTL, Moelker A, et al. Covered transjugular intrahepatic portosystemic shunt versus endoscopic therapy + β-blocker for prevention of variceal rebleeding. Hepatology. 2016;63:581–589.
   PubMed Web of Science ®Google Scholar
• Perarnau JM, Le Gouge A, Nicolas C, et al. Covered vs. uncovered stents for transjugular intrahepatic portosystemic shunt: a randomized controlled trial. J Hepatol. 2014;60:962–968.
   PubMed Web of Science ®Google Scholar
• Vignali C, Bargellini I, Grosso M, et al. TIPS with expanded polytetrafluoroethylene-covered stent: results of an Italian multicenter study. Am J Roentgenol. 2005;185:472–480.
   PubMed Web of Science ®Google Scholar
• Rinaldi L, Nascimbeni F, Giordano M, et al. Clinical features and natural history of cryptogenic cirrhosis compared to hepatitis C virus-related cirrhosis. World J Gastroenterology. 2017;23:1458.
   PubMed Web of Science ®Google Scholar
• García-Pagán JC, Caca K, Bureau C, et al. Early use of TIPS in patients with cirrhosis and variceal bleeding. N Engl J Med. 2010;4:2370–2379.
   Web of Science ®Google Scholar
• Garcia-Pagán JC, Di Pascoli M, Caca K, et al. Use of early-TIPS for high-risk variceal bleeding: results of a post-RCT surveillance study. J Hepatol. 2013;58:45–50.
   PubMed Web of Science ®Google Scholar
• Charon J-PM, Alaeddin FH, Pimpalwar SA, et al. Results of a retrospective multicenter trial of the Viatorr expanded polytetrafluoroethylene–covered stent-graft for transjugular intrahepatic portosystemic shunt creation. J Vasc Interv Radiol. 2004;15:1219–1230.
   PubMed Web of Science ®Google Scholar
• D’Amico G, Garcia-Pagan JC, Luca A, et al. Hepatic vein pressure gradient reduction and prevention of variceal bleeding in cirrhosis: a systematic review. Gastroenterology. 2006;131:1611–1624.
   PubMed Web of Science ®Google Scholar
• Addley J, Tham TC, Cash WJ. Use of portal pressure studies in the management of variceal haemorrhage. World J Gastrointest Endosc. 2012;4:281–289.
   PubMedGoogle Scholar
• Pattynama PMT, Wils A, van der Linden E, et al. Embolization with the Amplatzer vascular plug in TIPS patients. Cardiovasc Intervent Radiol. 2007;30:1218–1221.
   PubMed Web of Science ®Google Scholar
• Tesdal IK, Filser T, Weiss C, et al. Transjugular intrahepatic portosystemic shunts: adjunctive embolotherapy of gastroesophageal collateral vessels in the prevention of variceal rebleeding. Radiology. 2005;236:360–367.
   PubMed Web of Science ®Google Scholar
• Gaba RC, Bui JT, Cotler SJ, et al. Rebleeding rates following TIPS for variceal hemorrhage in the Viatorr era: TIPS alone versus TIPS with variceal embolization. Hepatol Int. 2010;4:749–756.
   PubMed Web of Science ®Google Scholar
• Gaba RC, Omene BO, Podczerwinski ES, et al. TIPS for treatment of variceal hemorrhage: clinical outcomes in 128 patients at a single institution over a 12-year period. J Vasc Interv Radiol. 2012;23:227–235.
   PubMed Web of Science ®Google Scholar
• Chen S, Li X, Wei B, et al. Recurrent variceal bleeding and shunt patency: prospective randomized controlled trial of transjugular intrahepatic portosystemic shunt alone or combined with coronary vein embolization. Radiology. 2013;268:900–906.
   PubMed Web of Science ®Google Scholar
• He F, Dai S, Xiao Z, et al. Pathological predictors of shunt stenosis and hepatic encephalopathy after transjugular intrahepatic portosystemic shunt. BioMed Res Int. 2016;2016:1–8.
   Web of Science ®Google Scholar
• Cejna M. Should stent-grafts replace bare stents for primary transjugular intrahepatic portosystemic shunts? Semin Intervent Radiol. 2005;22:287–299.
   PubMedGoogle Scholar
• D’Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol. 2006;44:217–231.
   PubMed Web of Science ®Google Scholar
• Bureau C, Thabut D, Oberti F, et al. Transjugular intrahepatic portosystemic shunts with covered stents increase transplant-free survival of patients with cirrhosis and recurrent ascites. Gastroenterology. 2017;152:157–163.
   PubMed Web of Science ®Google Scholar
• Chung H-H, Razavi MK, Sze DY, et al. Portosystemic pressure gradient during transjugular intrahepatic portosystemic shunt with Viatorr stent graft: what is the critical low threshold to avoid medically uncontrolled low pressure gradient related complications?: portosystemic pressure gradient. J Gastroenterol Hepatol. 2007;23:95–101.
   Web of Science ®Google Scholar
• Yao J, Zuo L, An G, et al. Risk factors for hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with hepatocellular carcinoma and portal hypertension. J Gastrointest Liver Dis. 2015;24:301–307.
   PubMed Web of Science ®Google Scholar
• Riggio O, Merlli M, Pedretti G, et al. Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt. Incidence and risk factors. Dig Dis Sci. 1996;41:578–584.
   PubMed Web of Science ®Google Scholar